Now showing items 1-3 of 3

    • Effects of social defeat on iK-ba inflammatory signaling in male c57BL/6J 

      Johnson, Christopher; Davis, Randall; Buck, Daniel; McCracken, Kelly (Oklahoma State University Center for Health Services, 2020-02-28)
      An estimated 30 million people in the United States have been diagnosed with mood and anxiety disorders. Unfortunately, many of these patients do not adequately respond to current pharmacotherapies, so developing new drugs ...
    • Protective effects of β-Funaltrexamine against LPS-induced CCL2 expression and behavioral deficits 

      Myers, Stephanie; Buck, Daniel J.; McCracken, Kelly; Curtis, J. Thomas; Davis, Randall L. (Oklahoma State University Center for Health Sciences, 2023-02-17)
      Background: Inflammation is present in both neurological and peripheral disorders. Specifically, inflammation is one of the common factors in diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), mood disorders ...
    • β-Funaltrexamine protects against lipopolysaccharide-induced neuroinflammation and behavioral impairment 

      Myers, Stephanie; Buck, Daniel J.; McCracken, Kelly; Curtis, J. Thomas; Davis, Randall L. (Oklahoma State University Center for Health Sciences, 2022-02-18)
      Background: One of the commonalities present in a multitude of neurological disorders is inflammation. For this reason, targeting inflammation has emerged as a viable option for the potential treatment of neurological ...